Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25640 | 276 | 41.5 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
1 | 3 | CHEMISTRY, ORGANIC//TETRAHEDRON LETTERS//JOURNAL OF ORGANIC CHEMISTRY | 237069 |
288 | 2 | CHEMISTRY, ORGANIC//ALLYLATION//TETRAHEDRON LETTERS | 18901 |
25640 | 1 | SELINEXOR//XPO1//CRM1 INHIBITOR | 276 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SELINEXOR | authKW | 885080 | 3% | 100% | 8 |
2 | XPO1 | authKW | 779043 | 5% | 54% | 13 |
3 | CRM1 INHIBITOR | authKW | 774445 | 3% | 100% | 7 |
4 | CRM1 | authKW | 629338 | 12% | 18% | 32 |
5 | KPT 330 | authKW | 553175 | 2% | 100% | 5 |
6 | EXPORTIN 1 | authKW | 448062 | 3% | 45% | 9 |
7 | CALLYSTATIN A | authKW | 442540 | 1% | 100% | 4 |
8 | S109 | authKW | 442540 | 1% | 100% | 4 |
9 | LEPTOMYCIN | authKW | 417003 | 3% | 54% | 7 |
10 | REV EXPORT INHIBITOR | authKW | 354031 | 1% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 851 | 30% | 0% | 82 |
2 | Chemistry, Organic | 372 | 18% | 0% | 49 |
3 | Biotechnology & Applied Microbiology | 259 | 14% | 0% | 39 |
4 | Hematology | 226 | 9% | 0% | 26 |
5 | Pharmacology & Pharmacy | 190 | 17% | 0% | 48 |
6 | Microbiology | 158 | 11% | 0% | 31 |
7 | Cell Biology | 144 | 13% | 0% | 37 |
8 | Immunology | 85 | 10% | 0% | 28 |
9 | Chemistry, Medicinal | 59 | 5% | 0% | 14 |
10 | Biochemistry & Molecular Biology | 37 | 14% | 0% | 39 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INSITITUTE NERVOUS SYST DIS | 165950 | 1% | 50% | 3 |
2 | CREAT FUNCT NEW MOL MOL ASSEMBLIES | 147512 | 1% | 67% | 2 |
3 | BEIJING CLIN STUDY ANTICANCER | 110635 | 0% | 100% | 1 |
4 | BIOFIS CSIC | 110635 | 0% | 100% | 1 |
5 | BLOOD DISORDERS CANC THER EUT | 110635 | 0% | 100% | 1 |
6 | FUJIAN MED UNIV CLIN TEACHING HOSP | 110635 | 0% | 100% | 1 |
7 | INSERM U309EQUIPE ASSEMBLAGE REGULAT PAREIL | 110635 | 0% | 100% | 1 |
8 | LURIE FAMILY IMAGING PEDIAT ONCOL | 110635 | 0% | 100% | 1 |
9 | M2GEN BIOTECHNOL | 110635 | 0% | 100% | 1 |
10 | MEDMED SERV Y MEM HOSP | 110635 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIBIOTICS | 13039 | 10% | 0% | 28 |
2 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 5897 | 2% | 1% | 6 |
3 | SEMINARS IN CANCER BIOLOGY | 893 | 1% | 0% | 3 |
4 | ONCOTARGET | 889 | 4% | 0% | 10 |
5 | JOURNAL OF BIOMOLECULAR SCREENING | 576 | 1% | 0% | 3 |
6 | JOURNAL OF NATURAL TOXINS | 467 | 0% | 0% | 1 |
7 | CURRENT CANCER DRUG TARGETS | 462 | 1% | 0% | 2 |
8 | MOLECULAR CANCER THERAPEUTICS | 429 | 1% | 0% | 4 |
9 | NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY | 426 | 1% | 0% | 2 |
10 | BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 419 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SELINEXOR | 885080 | 3% | 100% | 8 | Search SELINEXOR | Search SELINEXOR |
2 | XPO1 | 779043 | 5% | 54% | 13 | Search XPO1 | Search XPO1 |
3 | CRM1 INHIBITOR | 774445 | 3% | 100% | 7 | Search CRM1+INHIBITOR | Search CRM1+INHIBITOR |
4 | CRM1 | 629338 | 12% | 18% | 32 | Search CRM1 | Search CRM1 |
5 | KPT 330 | 553175 | 2% | 100% | 5 | Search KPT+330 | Search KPT+330 |
6 | EXPORTIN 1 | 448062 | 3% | 45% | 9 | Search EXPORTIN+1 | Search EXPORTIN+1 |
7 | CALLYSTATIN A | 442540 | 1% | 100% | 4 | Search CALLYSTATIN+A | Search CALLYSTATIN+A |
8 | S109 | 442540 | 1% | 100% | 4 | Search S109 | Search S109 |
9 | LEPTOMYCIN | 417003 | 3% | 54% | 7 | Search LEPTOMYCIN | Search LEPTOMYCIN |
10 | REV EXPORT INHIBITOR | 354031 | 1% | 80% | 4 | Search REV+EXPORT+INHIBITOR | Search REV+EXPORT+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GRAVINA, GL , SENAPEDIS, W , MCCAULEY, D , BALOGLU, E , SHACHAM, S , FESTUCCIA, C , (2014) NUCLEO-CYTOPLASMIC TRANSPORT AS A THERAPEUTIC TARGET OF CANCER.JOURNAL OF HEMATOLOGY & ONCOLOGY. VOL. 7. ISSUE . P. - | 45 | 51% | 21 |
2 | CROCHIERE, ML , BALOGLU, E , KLEBANOV, B , DONOVAN, S , DEL ALAMO, D , LEE, M , KAUFFMAN, M , SHACHAM, S , LANDESMAN, Y , (2016) A METHOD FOR QUANTIFICATION OF EXPORTIN-1 (XPO1) OCCUPANCY BY SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) COMPOUNDS.ONCOTARGET. VOL. 7. ISSUE 2. P. 1863 -1877 | 28 | 74% | 0 |
3 | CROCHIERE, M , KASHYAP, T , KALID, O , SHECHTER, S , KLEBANOV, B , SENAPEDIS, W , SAINT-MARTIN, JR , LANDESMAN, Y , (2015) DECIPHERING MECHANISMS OF DRUG SENSITIVITY AND RESISTANCE TO SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) COMPOUNDS.BMC CANCER. VOL. 15. ISSUE . P. - | 41 | 47% | 1 |
4 | REICHARD, HA , RIEGER, JC , MICALIZIO, GC , (2008) TOTAL SYNTHESIS OF CALLYSTATIN A BY TITANIUM-MEDIATED REDUCTIVE ALKYNE-ALKYNE CROSS-COUPLING.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 47. ISSUE 41. P. 7837 -7840 | 31 | 72% | 17 |
5 | BONAZZI, S , EIDAM, O , GUTTINGER, S , WACH, JY , ZEMP, I , KUTAY, U , GADEMANN, K , (2010) ANGUINOMYCINS AND DERIVATIVES: TOTAL SYNTHESES, MODELING, AND BIOLOGICAL EVALUATION OF THE INHIBITION OF NUCLEOCYTOPLASMIC TRANSPORT.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 132. ISSUE 4. P. 1432 -1442 | 35 | 51% | 46 |
6 | ISHIZAWA, J , KOJIMA, K , HAIL, N , TABE, Y , ANDREEFF, M , (2015) EXPRESSION, FUNCTION, AND TARGETING OF THE NUCLEAR EXPORTER CHROMOSOME REGION MAINTENANCE 1 (CRM1) PROTEIN.PHARMACOLOGY & THERAPEUTICS. VOL. 153. ISSUE . P. 25 -35 | 35 | 43% | 8 |
7 | SENAPEDIS, WT , BALOGLU, E , LANDESMAN, Y , (2014) CLINICAL TRANSLATION OF NUCLEAR EXPORT INHIBITORS IN CANCER.SEMINARS IN CANCER BIOLOGY. VOL. 27. ISSUE . P. 74 -86 | 50 | 30% | 17 |
8 | TURNER, JG , DAWSON, JL , GRANT, S , SHAIN, KH , DALTON, WS , DAI, Y , MEADS, M , BAZ, R , KAUFFMAN, M , SHACHAM, S , ET AL (2016) TREATMENT OF ACQUIRED DRUG RESISTANCE IN MULTIPLE MYELOMA BY COMBINATION THERAPY WITH XPO1 AND TOPOISOMERASE II INHIBITORS.JOURNAL OF HEMATOLOGY & ONCOLOGY. VOL. 9. ISSUE . P. - | 26 | 58% | 1 |
9 | RIAZ, W , BURKE, N , MAHIPAL, A , (2014) SELINEXOR EXPORTIN-1(XPO1) INHIBITOR ONCOLYTIC.DRUGS OF THE FUTURE. VOL. 39. ISSUE 10. P. 685 -692 | 23 | 72% | 1 |
10 | DE CESARE, M , COMINETTI, D , DOLDI, V , LOPERGOLO, A , DERACO, M , GANDELLINI, P , FRIEDLANDER, S , LANDESMAN, Y , KAUFFMAN, MG , SHACHAM, S , ET AL (2015) ANTI-TUMOR ACTIVITY OF SELECTIVE INHIBITORS OF XPO1/CRM1-MEDIATED NUCLEAR EXPORT IN DIFFUSE MALIGNANT PERITONEAL MESOTHELIOMA: THE ROLE OF SURVIVIN.ONCOTARGET. VOL. 6. ISSUE 15. P. 13119 -13132 | 25 | 61% | 2 |
Classes with closest relation at Level 1 |